Wall Street Zen Downgrades Nu Skin Enterprises (NYSE:NUS) to Buy

Key Points

• Nu Skin Enterprises has been downgraded by Wall Street Zen from a "strong-buy" to a "buy" rating, indicating a shift in analyst sentiment regarding the stock's performance.
• The company's stock experienced a decline of 6.9%, with current trading at $11.46 and a 52-week range between $5.32 and $12.40.
• Despite the downgrade, Nu Skin reported earnings of $0.43 per share for the last quarter, surpassing consensus expectations of $0.25.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued to investors on Friday.

Separately, Zacks Research upgraded shares of Nu Skin Enterprises to a "hold" rating in a research report on Tuesday, August 12th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $6.88.

Nu Skin Enterprises Stock Down 6.9%

NUS opened at $11.46 on Friday. Nu Skin Enterprises has a 52 week low of $5.32 and a 52 week high of $12.40. The business has a 50 day moving average price of $9.95 and a two-hundred day moving average price of $8.16. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The company has a market cap of $567.12 million, a PE ratio of 5.70 and a beta of 0.92.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.18. The company had revenue of $386.14 million for the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, research analysts anticipate that Nu Skin Enterprises will post 1.05 EPS for the current year.

Insiders Place Their Bets

In related news, Director Daniel W. Campbell sold 23,391 shares of the firm's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $12.10, for a total value of $283,031.10. Following the completion of the sale, the director owned 53,375 shares in the company, valued at $645,837.50. This trade represents a 30.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Laura Nathanson sold 6,489 shares of the business's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $12.22, for a total transaction of $79,295.58. Following the sale, the director directly owned 33,149 shares in the company, valued at approximately $405,080.78. This represents a 16.37% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 58,926 shares of company stock worth $711,364. Corporate insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On Nu Skin Enterprises

Hedge funds and other institutional investors have recently modified their holdings of the stock. First Trust Advisors LP acquired a new stake in shares of Nu Skin Enterprises in the 4th quarter worth approximately $295,000. Price T Rowe Associates Inc. MD raised its holdings in Nu Skin Enterprises by 5.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,711 shares of the company's stock worth $371,000 after purchasing an additional 2,702 shares during the last quarter. Algert Global LLC purchased a new stake in Nu Skin Enterprises during the fourth quarter worth $125,000. Ameriprise Financial Inc. grew its holdings in Nu Skin Enterprises by 115.1% in the fourth quarter. Ameriprise Financial Inc. now owns 238,237 shares of the company's stock valued at $1,641,000 after purchasing an additional 127,474 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its holdings in Nu Skin Enterprises by 61.4% in the fourth quarter. BNP Paribas Financial Markets now owns 231,260 shares of the company's stock valued at $1,593,000 after purchasing an additional 87,941 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.